The recommended molecular approach for establishing the diagnosis of distal myopathies, including ANO5 muscle disease, generally includes a multigene panel or comprehensive genomic testing, with exome sequencing being more common than genome sequencing. The gene discussed is ANO5; the disease is distal myopathy.